Cargando…
Relapses of Anti-NMDAR, Anti-GABABR and Anti-LGI1 Encephalitis: A Retrospective Cohort Study
OBJECTIVE: To investigate the relapse rate and study the factors that may predict the subsequent relapse in anti-NMDAR, anti-GABABR and anti-LGI1 encephalitis in Northeast China. METHODS: In the retrospective cohort study, we consecutively enrolled patients with anti-N1MDAR, anti-GABABR and anti-LGI...
Autores principales: | Zhong, Rui, Chen, Qingling, Zhang, Xinyue, Zhang, Hanyu, Lin, Weihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218051/ https://www.ncbi.nlm.nih.gov/pubmed/35757705 http://dx.doi.org/10.3389/fimmu.2022.918396 |
Ejemplares similares
-
Risk Factors for Mortality in Anti-NMDAR, Anti-LGI1, and Anti-GABABR Encephalitis
por: Zhong, Rui, et al.
Publicado: (2022) -
Comprehensive B-Cell Immune Repertoire Analysis of Anti-NMDAR Encephalitis and Anti-LGI1 Encephalitis
por: Feng, Jingjing, et al.
Publicado: (2021) -
Anti‐LGI1, anti‐GABABR, and Anti‐CASPR2 encephalitides in Asia: A systematic review
por: Ghimire, Prinska, et al.
Publicado: (2020) -
Positive LGI1 Antibodies in CSF and Relapse Relate to Worse Outcome in Anti-LGI1 Encephalitis
por: Cui, Li-li, et al.
Publicado: (2021) -
Seizures and risk of epilepsy in anti‐NMDAR, anti‐LGI1, and anti‐GABA(B)R encephalitis
por: Shen, Chun‐Hong, et al.
Publicado: (2020)